Clinical Study
Effectiveness of a Novel Device in the Reduction of Cesarean Deliveries
Table 1
(Efforts to manage the cesarean delivery rate) baseline information by treatment. Efficacy population.
| Summary | Treatment group | P value | HEM-AVERT | Control |
| Number of patients | 50 | 48 | | Weight (lbs) | | | | N | 50 | 48 | 0.61881 | Mean (SD) | 180.6 (44.46) | 183.2 (43.79) | Median | 171.5 | 174.0 | Min, max | 108, 305 | 122, 350 | Age | | | | N | 50 | 48 | 0.71921 | Mean (SD) | 25.0 (5.29) | 25.0 (6.24) | Median | 26.0 | 24.0 | Min, max | 14, 36 | 16, 41 | Previous births | 30 (60.0%) | 23 (47.9%) | 0.31082 | Number of previous cesareans | | | | 0 | 48 (96.0%) | 46 (95.8%) | 0.96693 | 1 | 2 (4.0%) | 2 (4.2%) | Number of previous vaginal births | | | | 0 | 20 (40.0%) | 25 (52.1%) | 0.35013 | 1 | 15 (30.0%) | 11 (22.9%) | 2 | 6 (12.0%) | 4 (8.3%) | 3 | 6 (12.0%) | 4 (8.3%) | 4 | 2 (4.0%) | 2 (4.2%) | 5 | 1 (2.0%) | 0 | 6 | 0 | 2 (4.2%) |
|
|
Statistical Method:
1Wilcoxon-Rank Sum test.
2Fisher’s Exact test.
3Cochran-Mantel-Haenszel test.
|